Cargando…
Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches
Hyperphosphatemia is a secondary disorder of chronic kidney disease that causes vascular calcifications and bone-mineral disorders. As per the US Centers for Disease Control and Prevention, renal damage requires first-priority medical attention for patients with COVID-19; according to a Johns Hopkin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221414/ https://www.ncbi.nlm.nih.gov/pubmed/37241191 http://dx.doi.org/10.3390/medicina59050959 |